Olga N. Scheglovitova

Olga N. Scheglovitova

Auto-generated profile, based on publicly available information

Olga N. Scheglovitova

N. F. Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1993 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
OSOlga Scheglovitova
Olga Scheglovitova
MCMaria Capobianchi
Maria Capobianchi
GAGuido Antonelli
Guido Antonelli
DGD. Guanmu
D. Guanmu
FDF. Dianzani
F. Dianzani

22 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AKAlexey Kostarnoy
Alexey Kostarnoy
PGPetya G. Gancheva
Petya G. Gancheva
IKIgor Kireev
Igor Kireev
ASAndrey Solovyev
Andrey Solovyev
BLBernd Lepenies
Bernd Lepenies
AGAlexander L. Gintsburg
Alexander L. Gintsburg
Cellular lipid uptake (through endocytosis) is a basic physiological process. Dysregulation of this process underlies the pathogenesis of diseases such as atherosclerosis, obesity, diabetes, and cancer. However, to date, only some mechanisms of lipid endocytosis have been discovered. Here, we show a previously unknown mechanism of lipid cargo uptake into cells mediated by the receptor Mincle. We found that the receptor Mincle, previously shown to be a pattern recognition receptor of the innate immune system, tightly binds a range of self-lipids. Moreover, we revealed the minimal molecular motif in lipids that is sufficient for Mincle recognition. Superresolution microscopy showed that Mincle forms vesicles in cytoplasm and colocalizes with added fluorescent lipids in endothelial cells but does not colocalize with either clathrin or caveolin-1, and the added lipids were predominantly incorporated in vesicles that expressed Mincle. Using a model of ganglioside GM3 uptake in brain vessel endothelial cells, we show that the knockout of Mincle led to a dramatic decrease in lipid endocytosis. Taken together, our results have revealed a fundamental lipid endocytosis pathway, which we call Mincle-mediated endocytosis (MiME), and indicate a prospective target for the treatment of disorders of lipid metabolism, which are rapidly increasing in prevalence.

24 April 2024 in Journal of Innovative Optical Health Sciences
Verified
Journal Article
Open access
MMM. K. Maksimov
M. K. Maksimov
PEPetr Ermolinskiy
Petr Ermolinskiy
OSO. N. Scheglovitova
O. N. Scheglovitova
NSN. N. Sklyankina
N. N. Sklyankina
AMA. V. Muravyov
A. V. Muravyov
APAlexander V Priezzhev
Alexander V Priezzhev
Red blood cells (RBCs) are the most abundant human blood cells. RBC aggregation and deformation strongly determine blood viscosity which impacts hemorheology and microcirculation. In turn, RBC properties depend on different endogenous and exogenous factors. One such factor is nitric oxide (NO), which is mainly produced by endothelial cells (EC) from L-arginine amino acid in the circulatory system. Since the mechanisms of the RBC-endothelium interplay are not clear up to date and considering its possible clinical importance, the aims of this study are to investigate in vitro: (1) The effect of L-arginine induced NO on RBC aggregation and adhesion to endothelium; (2) the NO effect on RBC aggregation and deformation induced by L-arginine and sodium nitroprusside without the presence of endothelium in the samples. The RBC aggregation and adhesion to a monolayer of EC were studied using optical tweezers (OT). The RBC deformability and aggregation without endothelium in the samples were studied using the flow chamber method and Myrenne aggregometer. We confirmed that NO increases deformability and decreases aggregation of RBCs. We showed that the soluble guanylate cyclase pathway appears to be the only NO signaling pathway involved. In the samples with the endothelium, the “bell-shaped” dependence of RBC aggregation force on L-arginine concentration was observed, which improves our knowledge about the process of NO production by endothelium. Additionally, data related to L-arginine accumulation by endothelium were obtained: Necessity of the presence of extracellular L-arginine stated by other authors was put under question. In our study, NO decreased the RBC-endothelium adhesion, however, the tendency appeared to be weak and was not confirmed in another set of experiments. To our knowledge, this is the first attempt to measure the forces of RBC adhesion to endothelium monolayer with OT.

20 October 2026 in International Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
MMMatvei Maksimov
Matvei Maksimov
PEPetr Ermolinskiy
Petr Ermolinskiy
OSOlga Scheglovitova
Olga Scheglovitova
MKMarina Kapkaeva
Marina Kapkaeva
IFIrina Frolova
Irina Frolova
APAlexander V Priezzhev
Alexander V Priezzhev
Background: Interferon alpha (IFN-α) is an antiviral drug with widespread clinical use. Several studies report its effects on the endothelium, including the regulation of nitric oxide (NO) production. Such effects may cause adverse effects in patients with altered blood microrheology, as the interaction between red blood cells (RBCs) and the endothelium is a key factor governing blood microrheology. This study aimed to investigate the effect of IFN-α on the RBC–endothelium system in vitro. Methods: Human umbilical vein endothelial cells (HUVECs) were used as a model of vascular endothelium; human RBCs were obtained from healthy donors, and the forces of intercellular interactions were measured using optical tweezers. Statistical significance was assessed using the Mann–Whitney U test. Results: In the short-term exposure (15–60 minutes), the addition of IFN-α decreased RBC aggregation forces indirectly via the activation of the capacity of HUVECs to produce signaling molecules. Long-term (24 hours) HUVEC incubation with IFN-α had almost no effect, and long-term IFN-α incubation followed by short-term IFN-α reintroduction resulted in a weaker effect at higher concentrations. In the latter case, RBC–HUVEC adhesion decreased at certain concentrations. The minimal sample size comprised five measurements for each of the three donors at each IFN-α concentration. Conclusions: These findings reveal a complex interplay between interferon, endothelium, and RBCs, which should be considered in certain clinical applications of IFN-α. In particular, short-term endothelial exposure to IFN-α can decrease RBC aggregation, which may be helpful or harmful depending on the clinical condition of the patients. Long-term IFN-α treatment followed by short-term IFN-α exposure can decrease RBC–endothelium adhesion forces, altering blood microrheology.

1 January 2026 in Immunologiya
Verified
Journal Article
Closed access
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
VPV.V. Poloskov
V.V. Poloskov
APAlexander Vasilyevich Pronin
Alexander Vasilyevich Pronin
ASAlexander Sanin
Alexander Sanin
OSO.N. Shcheglovitova
O.N. Shcheglovitova
FEF.I. Ershov
F.I. Ershov